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The value of animal models in advancing 
our understanding of the disease mech-
anisms in epidermolysis bullosa (EB) 
has been amply demonstrated by the 
development of genetically modified 
mice that recapitulate the features of EB 
variants. In addition, a number of natu-
rally occurring mutations resulting in 
blistering phenotypes in larger animals, 
such as dogs, sheep, and horses, have 
been identified (Jiang and Uitto, 2005). 
A task force was recently convened to 
evaluate the status of animal models and 
make recommendations for the future 
development of such model systems for 
EB.* The panel discussed the advantages 
and disadvantages of existing mouse 
models (Table 1). Furthermore, the group 
updated the inventory of spontaneous 
animal models mimicking features of EB 
(Table 2). This report includes inform-
ation available as of February 2010.
Transgenic mice are valuable for 
dissecting the molecular mecha-
nisms of EB subtypes. Although the 
direct deleterious effects of a missing 
adhesion molecule in the skin are well 
table 1. Selective examples of transgenic mice developed as models for different forms of epidermolysis bullosa
Human disease model1 mouse gene defect Approach2 phenotypic features references
EBS Krt5 GKO Severe phenotype with high postnatal 
lethality in –/– mice; subtle phenotype in 
heterozygotes
Peters et al., 2001
EBS-MD Plec1 GKO Postnatal lethality Andrä et al., 1997
EBS-MD Plec1 CKO Mosaic deletion of plectin in the skin; 
localized EBS
Ackerl et al., 2007
EBS-Ogna Plec1 KI Viable, fertile, mimics human disease Wiche et al., unpublished
JEB-Herlitz Lama3 GKO Severe blistering, early lethality Ryan et al., 1999
JEB-Herlitz Lamb3 GKO Naturally occurring mutation with severe 
blistering
Kuster et al., 1997
JEB-Herlitz Lamc2 GKO Severe blistering with early lethality Meng et al., 2003
JEB-other Col17a1 GKO Skin blistering with survival up to 6 months Nishie et al., 2007;
Bubier et al., 2010
JEB-other (PA) Itgb4 CKO Skin blistering, loss of hemidesmosomes Raymond et al., 2005
JEB-other Itga3 CKO Skin microblistering, loss of hair Margadant et al., 2009
RDEB-HS Col7a1 GKO Severe blistering of the skin and mucous 
membranes; death during the first week 
of life
Heinonen et al., 1999
RDEB-severe generalized Col7a1 HYPO Recapitulates features of severe RDEB with 
a life span up to 150 days
Fritsch et al., 2008
RDEB Col7a1 CKO Conditional inactivation either in all cells 
(β-actin promoter) or in keratinocytes (KRT 
promoter); localized symptoms of RDEB 
after treatment with tamoxifen
Bruckner-Tuderman et al., 
unpublished
Kindler syndrome Fermt1 GKO Skin atrophy and intestinal epithelial dys-
function with perinatal lethality
Ussar et al., 2008
1EBS, EB simplex; EBS-MD, EB simplex with muscular dystrophy; HS, Hallopeau-Siemens variant; JEB, junctional EB; PA, pyloric atresia; RDEB, recessive dystrophic EB. 
2CKO, conditional “knock-out”; GKO, germline “knock-out” of the gene by targeted ablation; HYPO, hypomorphic mouse with about 10% expression of the Col7a1 in 
comparison to wild-type mice; KI, “knock-in” of a dominant gene.
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understood, intriguing novel informa-
tion continues to emerge on the com-
plex secondary effects mediated by 
signaling pathways and other cell sys-
tems that modify the EB phenotypes. 
Examples include the transforming 
growth factor-β-induced, myofibro-
blast-mediated contractile fibrosis in 
severe dystrophic EB (DEB) (Fritsch 
et al., 2008) and the Langerhans cell–
mediated inflammatory processes 
described in keratin 5–deficient mice 
(Roth et al., 2009).
Of particular interest was the suit-
ability of EB mouse models for preclini-
cal testing of gene-, protein-, and cell-
based therapies (Uitto, 2009). The col-
lagen VII knockout mouse (Heinonen et 
al., 1999) has been used for pilot studies 
of protein replacement- and cell-based 
treatments, but the short life span of the 
mouse has prevented long-term follow-
up and limited the interpretation of 
results (Chino et al., 2008, Remington 
et al., 2009, Tolar et al., 2009). The 
recently developed type VII collagen 
hypomorphic mouse and mice with 
milder phenotypes (Fritsch et al., 2008), 
which have a longer life span, may be 
better suited for preclinical testing, 
and they have already proven useful. 
For example, studies with successful 
fibroblast therapy for DEB have dem-
onstrated the suitability of the type VII 
collagen hypomorphic mouse for long-
term follow-up of therapeutic measures 
(Kern et al., 2009).
Genetically engineered mouse mod-
els have been generated for the major 
EB subtypes (EB simplex, junctional EB, 
and DEB; Table 1). EB mouse models 
have also proven valuable for studies 
on autoimmune bullous dermatoses, as 
demonstrated by Nishie et al. (2007), 
who modified a collagen XVII knockout 
mouse by crossing it with a mouse 
expressing human collagen XVII. The 
humanized mouse was then employed 
for studies on autoimmune reactions 
to the collagen, which is the major 
autoantigen in bullous pemphigoid.
The next priority will be to broad-
en the scope of viable mouse models 
involving genes or mutations involved in 
rare EB subtypes, such as EB with mus-
cular dystrophy, EB with pyloric atresia, 
and Kindler syndrome. However, this 
may be challenging in terms of resourc-
es and outcome because past work has 
shown that murine phenotypes can 
be unpredictable and may not fully 
recapitulate human disease. For exam-
ple, integrin α6β4 knockout mice did 
table 2. naturally occurring eB forms in animals 
Human disease model Animal species mutant protein / gene phenotypic features references 
EB simplex
EBS Bovine Krt5 Erosions, exungulation,  
intraepidermal cytolysis
Agerholm et al., 1994; Stocker et al., 
1995; Ford et al., 2005
EBS Dog ? Erosions, crusts Scott and Schultz, 1977
Junctional EB
JEB-Herlitz Horse Lamc2 Blistering, erosions, alopecia,  
neonatal teeth, LL separation
Frame et al., 1988; Spirito et al., 2002; 
Milenkovic et al., 2003; Baird et al., 2003
JEB-Herlitz Horse Lama3 Skin blistering Graves et al., 2009
JEB Bovine Integrin a6β4* Blistering, erosions, exungulation,  
no pyloric atresia
Guaguere et al., 2004
JEB-Herlitz Sheep Laminin 332* Blistering, erosions, crusts, LL separation, 
rudimentary hemidesmosomes
Ostmeier, 2009
JEB-Herlitz Dog ? Blistering, erosions, crusts, LL separation, 
rudimentary hemidesmosomes
Dunstan et al., 1988
JEB-other Dog Lama3 Blistering, erosions, crusts, LL 
separation, hypoplastic  
hemidesmosomes
Nagata et al.,1997; Sakurai et al., 2004; 
Cerquetella et al., 2005; Guaguere et al., 
2003; Capt et al., 2005; Spirito et al., 2006
JEB-other Dog Collagen XVII* Normal hemidesmosomes Olivry et al., 1997
JEB-other Cat Laminin 332* Ulcerations, nail anomalies, LL separation, 
abnormal hemidesmosomes
Alhaidari et al., 2005
JEB-other Mouse Lamb3 Skin and mucosal blistering, abnormal 
hemidesmosomes
Kuster et al., 1997
JEB Rat ? Skin blistering, LL separation, 
rudimentary hemidesmosomes
Brenneman et al., 2000
Dystrophic EB
RDEB-severe generalized Sheep Collagen VII* Blistering, crusts, exungulation,  
sub-LD separation, lack of AF
Bruckner-Tuderman et al., 1991;  
Perez et al., 2005
DEB Bovine ? Trauma-induced blistering,  
sub-LD separation
Thompson et al., 1985;  
Deprez et al., 1993
DEB Dog ? Reduced AF Nagata et al., 1995
RDEB-other Dog Col7a1 Generalized, non-lethal phenotype Palazzi et al., 2000; Baldeschi et al., 2003
DEB-other Cat Collagen VII* Ulcerations, nail dystrophy,  
sub-LD separation
Olivry et al., 1999
*Reduced protein expression, mutations not disclosed. AF, anchoring fibrils; LD, lamina densa; LL, lamina lucida.
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not exhibit pyloric atresia (van der Neut 
et al., 1996), the plectin knockout mice 
died soon after birth without apparent 
development of muscular dystrophy 
(Andrä et al., 1997), and the kindlin-1 
knockout mice had a limited skin phe-
notype (Ussar et al., 2008).
Finally, the task force discussed the 
need to develop a central repository for 
EB mouse models. It was unanimous-
ly felt that an already existing, well-
functioning site, such as the Jackson 
Laboratory (Bar Harbor, ME), would be 
an ideal repository for EB mouse mod-
els. Consequently, the panel recom-
mends establishing such a repository. 
Such arrangements are predicated upon 
clarification of questions concerning 
patents and other intellectual property 
rights as well as the cost of permanent 
maintenance of EB mouse models.
CONFLICT OF INTEREST
The authors state no conflict of interest.
*This task force convened in Vienna, Austria, 7 
September 2009, in the context of the EB 2009 
symposium, sponsored by DEBRA International 
(Uitto et al., 2010).
REfEREncEs
Ackerl R, Walko G, Fuchs P et al. (2007) 
Conditional targeting of plectin in prenatal 
and adult mouse stratified epithelia causes 
keratinocyte fragility and lesional epidermal 
barrier defects. J Cell Sci 120:2435–43
Agerholm JS (1994) Congenital generalized 
epidermolysis bullosa in a calf. Zentralbl 
Veterinarmed A 41:139–42
Alhaidari Z, Olivry T, Spadafora A et al. (2005) 
Junctional epidermolysis bullosa in two 
domestic shorthair kittens. Vet Dermatol 
16:69–73
Andrä K, Lassmann H, Bittner R et al. (1997) 
Targeted inactivation of plectin reveals essential 
function in maintaining the integrity of skin, 
muscle, and heart cytoarchitecture. Genes Dev 
11:3143–56
Baird JD, Millon LV, Dileanis S et al. (2003) 
Junctional epidermolysis bullosa in Belgian 
draft horses. In: Proceedings of the 49th Annual 
Convention of the American Association of 
Equine Practitioners, New Orleans, LA, 122–6
Baldeschi C, Gache Y, Rattenholl A et al. (2003) 
Genetic correction of canine dystrophic 
epidermolysis bullosa mediated by retroviral 
vectors. Hum Mol Genet 12:1897–905
Brenneman KA, Olivry T, Dorman DC (2000) 
Rudimentary hemidesmosome formation 
in congenital generalized junctional 
epidermolysis bullosa in the Sprague–Dawley 
rat. Vet Pathol 37:336–9
Bruckner-Tuderman L, Guscetti F, Ehrensperger 
F (1991) Animal model for dermolytic 
mechanobullous disease. Sheep with recessive 
dystrophic epidermolysis bullosa lack collagen 
VII. J Invest Dermatol 96:452–8
Bubier JA, Sproule TJ, Alley LM et al. (2010) A 
mouse model of generalized non-Herlitz 
junctional epidermolysis bullosa. J Invest 
Dermatol Mar 25 [E-pub ahead of print]
Capt A, Spirito F, Guaguere E et al. (2005) Inherited 
junctional epidermolysis bullosa in the German 
pointer: establishment of a large animal model. 
J Invest Dermatol 124:530–5
Cerquetella M, Spaterna A, Beribe F et al. (2005) 
Epidermolysis bullosa in the dog: four cases. 
Vet Res Commun 29(Suppl 2):289–91
Chino T, Tamai K, Yamazaki T et al. (2008) Bone 
marrow cell transfer into fetal circulation can 
ameliorate genetic skin diseases by providing 
fibroblasts to the skin and inducing immune 
tolerance. Am J Pathol 173:803–14
Deprez P, Maenhout T, Decock H et al. (1993) 
Epidermolysis-bullosa in a calf—a case-report. 
Vlaams Diergen Tijds 62:155–9
Dunstan RW, Sills RC, Wilkinson JE et al. (1988) 
A disease resembling junctional epidermolysis 
bullosa in a toy poodle. Am J Dermatopathol 
10:442–7
Ford CA, Stanfield AM, Spelman RJ et al. (2005) 
A mutation in bovine keratin 5 causing 
epidermolysis bullosa simplex, transmitted by 
a mosaic sire. J Invest Dermatol 124:1170–6
Frame SR, Harrington DD, Fessler J et al. (1988) 
Hereditary junctional mechanobullous disease 
in a foal. J Am Vet Med Assoc 193:1420–4
Fritsch A, Löckermann S, Kern JS et al. (2008) A 
hypomorphic mouse model for dystrophic 
epidermolysis bullosa reveals disease 
mechanisms and responds to fibroblast therapy. 
J Clin Invest 118:1669–79
Graves KT, Henney PJ, Ennis RB (2009) Partial 
deletion of the LAMA3 gene is responsible for 
hereditary junctional epidermolysis bullosa in 
the American Saddlebred horse. Anim Genet 
40:35–41
Guaguere E, Berg K, Degorce-Rubioales F et al. 
(2004) FC-26 junctional epidermolysis bullosa 
in a Charolais calf with deficient expression of 
integrin α6β4. Vet Derm 15:28
Guaguere E, Capt A, Spirito F et al. (2003) 
L’Épidermolyse Bulleuse Jonctionelle du 
Braque allemand: un modèle canin spontané 
de L’Épidermolyse Bulleuse Jonctionelle de 
l’Homme. Bull Acad Vet France 157:47–52
Heinonen S, Männikkö M, Klement JF et al. (1999) 
Targeted inactivation of the type VII collagen 
gene (Col7a1) in mice results in severe 
blistering phenotype: a model for recessive 
dystrophic epidermolysis bullosa. J Cell Sci 
112:3641–8
Jiang Q-J, Uitto J (2005) Animal models of 
epidermolysis bullosa—targets for gene 
therapy. J Invest Dermatol 124:xi–xiii
Kern JS, Löckermann S, Fritsch A et al. (2009) 
Mechanisms of fibroblast cell therapy for 
dystrophic epidermolysis bullosa: high stability 
of collagen VII favors long-term skin integrity. 
Mol Ther 17:1605–15
Kuster JE, Guarnieri MH, Ault JG et al. (1997) IAP 
insertion in the murine LamB3 gene results 
in junctional epidermolysis bullosa. Mamm 
Genome 8:673–81
Margadant C, Raymond K, Kreft M et al. (2009) 
Integrin α3β1 inhibits directional migration 
and wound re-epithelialization in the skin. 
J Cell Sci 122:278–88
Meng X, Klement JF, Leperi DA et al. (2003) 
Targeted inactivation of murine laminin 
γ2-chain gene recapitulates human junctional 
epidermolysis bullosa. J Invest Dermatol 
121:720–31
Milenkovic D, Chaffaux S, Taourit S et al. (2003) A 
mutation in the LAMC2 gene causes the Herlitz 
junctional epidermolysis bullosa (H-JEB) in 
two French draft horse breeds. Genet Sel Evol 
35:249–56
Nagata M, Shimizu H, Masunaga T et al. (1995) 
Dystrophic form of inherited epidermolysis 
bullosa in a dog (Akita Inu). Br J Dermatol 
133:1000–3
Nagata M, Iwasaki T, Masuda H et al. (1997) Non-
lethal junctional epidermolysis bullosa in a 
dog. Br J Dermatol 137:445–9
Nishie W, Sawamura D, Goto M et al. (2007) 
Humanization of autoantigen. Nat Med 
13:378–83
Olivry T, Poujade-Delverdier A, Dunston S et al. 
(1997) Absent expression of collagen XVII 
(BPAG2, BP180) in canine familial localized 
junctional epidermolysis bullosa. Vet Dermatol 
8:203–12
Olivry T, Dunston SM, Marinkovich MP (1999) 
Reduced anchoring fibril formation and 
collagen VII immunoreactivity in feline 
dystrophic epidermolysis bullosa. Vet Pathol 
36:616–8
Ostmeier MU (2009) Hereditäre epidermolysis 
bullosa beim Schaf: histopathologische 
und ultrastrukturelle befunde sowie 
immunhistochemische untersuchungen 
zur expression von dermoepidermalen 
strukturproteinen (laminin 5 und kollagen VII). 
DVG Service: GmbH, Giessen, Germany
Palazzi X, Marchal T, Chabanne L et al. (2000) 
Inherited dystrophic epidermolysis bullosa 
in inbred dogs: a spontaneous animal model 
for somatic gene therapy. J Invest Dermatol 
115:135–7
Pérez V, Benavides J, Herrera E et al. (2005) 
Epidermolysis bullosa in Assaf lambs. In: 
Proceedings of the 23rd Meeting of the 
European Society of Veterinary Pathology, 
Naples, Italy, 171
Peters B, Kirfel J, Büssow H et al. (2001) Complete 
cytolysis and neonatal lethality in keratin 5 
knockout mice reveal its fundamental role in 
skin integrity and in epidermolysis bullosa 
simplex. Mol Biol Cell 12:1775–89
Raymond K, Kreft M, Janssen H et al. (2005) 
Keratinocytes display normal proliferation, 
survival and differentiation in conditional 
beta4-integrin knockout mice. J Cell Sci 
118:1045–60
Remington J, Wang X, Hou Y et al. (2009) Injection 
of recombinant human type VII collagen 
corrects the disease phenotype in a murine 
model of dystrophic epidermolysis bullosa. 
Mol Ther 17:26–33
Uitto et al.
Animal Models of Epidermolysis Bullosa: Update 2010
1488 Journal of Investigative Dermatology (2010), Volume 130 
by transfer of wild-type bone marrow cells. 
Blood 113:1167–74
Uitto J (2009) Progress in heritable skin diseases: 
translational implications of mutation 
analysis and prospects of molecular 
therapies. Acta Derm Venereol 89:228–35
Uitto J, McGrath JA, Rodeck U et al. (2010) 
Progress in epidermolysis bullosa research: 
toward treatment and cure. J Invest 
Dermatol, in press
Ussar S, Moser M, Widmaier M et al. (2008) Loss 
of Kindlin-1 causes skin atrophy and lethal 
neonatal intestinal epithelial dysfunction. 
PLoS Genet 4:e1000289
van der Neut R, Krimpenfort P, Calafat J (1996) 
Epithelial detachment due to absence of 
hemidesmosomes in integrin β4 null mice. 
Nat Genet 13:366
junctional mechanobullous disease in 
the Belgian horse. J Invest Dermatol 
119:684–91
Spirito F, Capt A, Del Rio M et al. (2006) 
Sustained phenotypic reversion of junctional 
epidermolysis bullosa dog keratinocytes: 
establishment of an immunocompetent 
animal model for cutaneous gene therapy. 
Biochem Bioph Res Commun 339:769–78
Stocker H, Lott G, Straumann U et al. (1995) 
Epidermolysis bullosa bei einem Kalb. 
Tierärztliche Praxis 23:123–6
Thompson KG, Crandell RA, Rugeley WW et 
al. (1985) A mechanobullous disease with 
sub-basilar separation in Brangus calves. Vet 
Pathol 22:283–5
Tolar J, Ishida-Yamamoto A, Riddle M et al. 
(2009) Correction of epidermolysis bullosa 
Roth W, Reuter U, Wohlenberg C et al. (2009) 
Cytokines as genetic modifiers in K5−/− 
mice and in human epidermolysis bullosa 
simplex. Hum Mutation 30:832–41
Ryan MC, Lee K, Miyashita Y et al. (1999) 
Targeted disruption of the LAMA3 gene in 
mice reveals abnormalities in survival and 
late stage differentiation of epithelial cells. 
J Cell Biol 145:1309–23
Sakurai K, Sekiguchi M, Momoi Y et al. (2004) 
Nonlethal junctional epidermolysis bullosa 
in a dog. Vet Derm 15(Suppl 1):41–69
Scott DW, Schultz RD (1977) Epidermolysis 
bullosa simplex in the Collie dog. J Am Vet 
Med Assoc 171:721–7
Spirito F, Charlesworth A, Linder K et al. (2002) 
Animal models for skin blistering conditions: 
absence of laminin 5 causes hereditary 
